IP Library › Granted Patent US 12,557,843
Granted Patent B2
US 12,557,843 · App. 16/873,820 · Granted Feb 24, 2026

Other than cannabinoids, flavonoids, and terpenes

Inventor: Raymond Louis Larson (Aliso Viejo, CA)
A24F40/42A24F40/10A61K31/05A61K31/352
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,557,843
App. No.
16/873,820
Granted
Feb 24, 2026
Kind
B2
Abstract

A pharmaceutical composition and administration apparatus includes a portable powered vaporizer with a mouthpiece, smokeless vaporizing element, and a removable chamber. The chamber contains a composition comprising tetrahydrocannabinol (THC), cannabidiol (CBD), FCC grade ethanol, flavoring, pharmaceutical grade nicotine, USP grade aqueous glycerine, USP/EP grade propylene glycol, and USP grade vegetable glycerine. In various formulas the THC may be at concentrations of 1-30%, 30-60% and 60-99%, while CBD concentrations may be 0-15% including other cannabinoids derived from extraction.

Claims (33)

1 . A composition of cannabinoids, terpenes, flavonoids comprising:

(a) Greater than 0% wt.-30% wt. of at least two Tetrahydrocan-type (THC), of at least one +Cannabitriol-type (CBT), of at least two +Cannabigerol-type (CBG), of at least two +Cannabichromene-type (CBC), of at least two Cannabiabinol-type (CBN) selected from a group consisting of: CBN-C 2 , CBD-C 4 , CBCV-C 3 , CBND-C 5 , CBND-C 3 , CBN-C 1 , CBN-C 5 , CBD-C 1 , CBDV-C 3 , CBCC 5 , CBDA-C 5 , CBDM-C 5 , CBO-C 5 , CBDM-C 5 , CBNMC 5 , CBT-C 5 , (E)-CBG-C 5 , (E)-CBGM-C 5 A, (Z)-CBG 5 A, (E)-CBGV-C 3 , (E)-CBGA-C 5 A, (E)-CBGAM-C 5 A, (E)-CBGVA-C 3 A, Delta-9-THC-C 5 , Delta-9-THC-C 4 , Delta-9-THCO-C 1 , Delta-9-THCV-C 3 , Delta-9-THCA-C 5 A, Delta-9-THCA-C 5 B, OTHC, CBG, CBN and CBC; and

(b) Greater than 0% wt.-30% wt. of at least twelve terpenes/Flavonoids selected from the group consisting of: fisetin, chrysin, baicalein, naringenin, epicatechin, pelargonidin, malvidin, sabinene hydrate, (−)-isospulegol, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, fenchol, cedrol, myrcene, limonene, linalool, a pinene, fenchol, borneol, terpineol, menthol and 3Carene;

wherein the composition is a beverage, and

wherein the cannabinoids are soluble in carbonated water.

2 . The composition of claim 1 , further comprising:

0% wt.-30% wt. alcohol;

0% wt.-35% wt. Hops; and

wherein the at least twelve terpenes/Flavonoids are selected from the group consisting of: fisetin, chrysin, baicalein, naringenin, epicatechin, pelargonidin, malvidin, myrcene, limonene, a pine, nerol, cedrol, frenchone, methol, terpineol, borneol and glycitein.

3 . The composition of claim 1 , further comprising:

Greater than 0% wt-30% wt. of four terpenes/Flavonoids are selected from the group consisting of: sabinene hydrate, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, and cedrol;

0% wt.-30% wt. alcohol;

0% wt.-35% wt. Hops; and

0% wt. cannabinoids.

4 . The composition of claim 1 , further comprising:

1% wt.-30% wt. of five terpenes/flavonoids selected from the group consisting of: sabinene hydrate, (−)-isospulegol, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, fenchol, cedrol, and linolool;

0% wt.-30% wt. alcohol;

0% wt.-35% wt. Hops; and

0% wt. cannabinoids.

5 . The composition of claim 1 , further comprising:

1% wt.-30% wt. of at least three additional terpenes/Flavonoids selected from the group consisting of: sabinene hydrate, (−)-isospulegol, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, fenchol, limonene and linolool.

6 . The composition of claim 1 , further comprising:

1% wt.-30% wt. of at least 10 terpenes/flavonoids selected from the group consisting of: fisetin, chrysin, baicalein, naringenin, epicatechin, pelargonidin, myrcene, limonene, menthol, borneol, apinens, nerol, linalool and glycitein; and

wherein combination of the cannabinoids (a) is other than cannabigerol-type (CBG) and the Remaining eight cannabinoids greater than 0%-15% wt.

7 . The composition of claim 1 , further comprising

1% wt-30% wt. of at least terpenes/Flavonoids selected from the group consisting of: sabinene hydrate, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, fenchol, cedrol; myrcene, methol, borneol, limonene, linalool, a pinen, fisetin, chrysin, baicalein, naringenin, epicatechin, pelargonidin, malvidin and glycitein;

0% wt.-30% wt. alcohol; and

0% wt.-35% wt. Hops.

8 . The composition of claim 1 , further comprising:

0% wt.-30% wt. alcohol;

0% wt.-35% wt. Hops;

1% wt.-30% wt. of at least ten terpenes/Flavonoids are selected from the group consisting of: sabinene hydrate, (−)-isospulegol, isoborneol, nerol, r-(+)-pulegone, geranyl acetate, myrcene, terpineol, fenchol, cedrol, fisetin, chrysin, baicalein, naringenin, epicatechin, pelargonidin, malvidin, and glycitein; and

wherein the combination of cannabinoids (a) are other than THC and the remaining Tetrahydrocan-type all nine cannabinoids greater than 1%-30% wt.

Continuity (3)
Provisional Application 63100380 · Mar 11, 2020
Provisional Application 63101278 · Apr 24, 2020
Related Publication 20250344763A1 · Nov 13, 2025
References Cited (29)
US 8673368B2 · Guy · 2014 [cited by examiner]
US 10568865B2 · Levy · 2020 [cited by examiner]
US 20100168448A1 · Flockhart · 2010 [cited by examiner]
US 20140271940A1 · Wurzer · 2014 [cited by examiner]
US 20150182455A1 · Llamas · 2015 [cited by examiner]
US 20150352044A1 · Benson · 2015 [cited by examiner]
US 20160243177A1 · Franklin · 2016 [cited by examiner]
US 20170231948A1 · Skuratovich · 2017 [cited by examiner]
US 20170333503A1 · Ayres · 2017 [cited by examiner]
US 20170367386A1 · McElvany · 2017 [cited by examiner]
US 20180133272A1 · Crowley · 2018 [cited by examiner]
US 20180147179A1 · Raber · 2018 [cited by examiner]
US 20190142034A1 · Forsythe · 2019 [cited by examiner]
US 20200281890A1 · Macnair · 2020 [cited by examiner]
CA 3076929A1 · 2019 [cited by examiner]
KR 20100011229A · 2010 [cited by examiner]
WO WO2018175992A1 · 2018 [cited by examiner]
WO WO2019100168 · 2019 [cited by examiner]
WO WO2019104442A1 · 2019 [cited by examiner]
McLafferty(https://www.mentalfloss.com/article/56540/why-does-carbonation-make-drinks-taste-good) May 2014 (Year: 2014). [cited by examiner]
Adventures in Homebrewing (https://blog.homebrewing.org/late-addition-malt-extract-late-addition-hops/#:˜:text=To%20make%20the%20best%20use,the%20darkening%20of%20your%20beer.) Apr. 9, 2018 (Year: 2018) (Year: 2018). [cited by examiner]
New Food Magazine (https://www.newfoodmagazine.com/article/15042/viscosity-measurements-food-products/) Oct. 27, 2014 (Year: 2014). [cited by examiner]
New Food Magazine (https://www.newfoodmagazine.com/article/15042/viscosity-measurements-food-products/) snagit pic converted to pdf (Year: 2014). [cited by examiner]
New Food Magazine (https://www.newfoodmagazine.com/article/15042/viscosity-measurements-food-products/) snagit pic converted to pdf additional page (Year: 2014). [cited by examiner]
Piomelli and Russo (The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD, Cannabis and Cannabinoid Research, vol. 1.1, 2016) (Year: 2016). [cited by examiner]
Fundación Canna (https://www.fundacion-canna.es/en/flavonoids) retrieved on Apr. 2, 2024 (Year: 2015). [cited by examiner]
Wayback machine reference date for Fundación Canna (https://www.fundacion-canna.es/en/flavonoids, retrieved on Apr. 2, 2024. Is used to show the reference date for the mentioned webpage. (Year: 2024). [cited by examiner]
Fischedick (Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9- Tetrahydrocannabinol-Producing [cited by examiner]
Romeyn (https://www.vogue.com/article/cannabis-terpene-cocktails-health-benefits) retrieved on Jul. 16, 2024, Aug. 9, 2017 (Year: 2017). [cited by examiner]